Endocrine, Bone & Healthy Ageing
Hormones regulate metabolism throughout life. Thyroid, adrenal and pituitary disorders influence weight, glucose, lipids and blood pressure; bone health depends on hormones, nutrition and kidney function; and ageing brings multiple coexisting conditions that require a holistic approach.
Hormones, bones and the ageing body.
Endocrine disorders frequently present as, or complicate, metabolic disease. Thyroid dysfunction can alter weight and lipids; Cushing’s syndrome and primary aldosteronism can cause diabetes and resistant hypertension. Recognising these conditions is essential to correct diagnosis and treatment.
Bone health is influenced by complex interactions involving hormones, nutrition, physical activity, ageing, kidney function and metabolic regulation. Osteoporosis and metabolic bone disorders are important causes of disability, and diabetes itself increases fracture risk.
Ageing is accompanied by changes in glucose regulation, body composition, muscle mass, cardiovascular function, kidney health and nutritional status. Older adults commonly live with several conditions at once. IMACH promotes person-centred care that balances benefits and risks, avoids over-treatment and preserves function and independence.
Key areas of scientific focus
Endocrinology
- Thyroid disorders and metabolism
- Adrenal disorders, Cushing’s syndrome and primary aldosteronism
- Pituitary disorders and metabolic effects
- Endocrine causes of secondary hypertension
- Vitamin D and calcium metabolism
- Endocrine disorders in special populations
Bone health
- Osteoporosis diagnosis and fracture-risk assessment
- Bone mineral density assessment
- Diabetes and bone fragility
- CKD-mineral and bone disorder
- Pharmacological osteoporosis therapies
- Bone health in ageing populations
Healthy ageing
- Metabolic changes with ageing
- Frailty and sarcopenia
- Diabetes in older adults and de-intensification
- Polypharmacy and medication safety
- Cognitive health and metabolic disease
- Falls, fracture prevention and nutrition in older age
Clinical challenges we address
Missed endocrine causes
Secondary causes of hypertension and diabetes are rarely screened for.
Osteoporosis treatment gap
Most people who have a fragility fracture are not treated afterwards.
Over-treatment in older adults
Tight targets can cause hypoglycaemia and falls.
Polypharmacy
Multiple medicines increase interactions and side-effects.
Muscle loss
Sarcopenia is under-recognised yet strongly affects outcomes.
Translating evidence into everyday care
IMACH promotes targeted endocrine testing, systematic fracture-risk assessment and individualised targets for older adults.
Pathway highlights:
| Care stage | Focus for clinicians |
|---|---|
| Screen for secondary causes | Thyroid tests; aldosterone and cortisol testing where indicated. |
| Assess bone | Fracture-risk tools, bone density, vitamin D, kidney function. |
| Assess function | Frailty, muscle strength, cognition and falls risk. |
| Individualise | Targets and therapies adapted to life expectancy and priorities. |
| Review medicines | Regular review to reduce polypharmacy. |
IMACH programmes in this area
Clinical endocrinology updates
Thyroid, adrenal and pituitary disorders in metabolic practice.
Osteoporosis workshops
Fracture-risk assessment and treatment.
Geriatric metabolic care
Diabetes and multimorbidity in older adults.
Sarcopenia & nutrition
Preserving muscle and function.
Deprescribing sessions
Safe medication review.
Who this area brings together
Endocrinologists, orthopaedic and spine specialists, geriatricians and primary care work together to protect function across the life course.
Questions we explore
- Which patients should be screened for primary aldosteronism?
- How should fracture risk be assessed in people with diabetes?
- When should diabetes treatment be de-intensified in older adults?
- How can sarcopenia be identified and treated?
Frequently asked questions
Why combine endocrinology, bone and ageing?
These areas share hormonal and metabolic mechanisms and increasingly affect the same patients, particularly older adults.
Is spine and orthopaedic care involved?
Yes — IMACH’s panel includes spine and orthopaedic expertise, relevant to osteoporosis and fracture care.
This page is intended for healthcare professionals and is educational in nature. It does not constitute medical advice or treatment recommendations for individual patients. Clinical decisions should follow current guidelines, local regulations and individual patient assessment.
Contribute to endocrine, bone and ageing care at IMACH.
Join as a member, faculty or research collaborator in this therapy area.